Baricitinib in Relapsing Giant Cell Arteritis

NCT03026504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Arteritis, Giant Cell

Interventions

DRUG: Baricitinib

Sponsor

Matthew J Koster

Collaborators

[object Object]